| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-05 |